About Consort Medical (OTCMKTS:CSRMY)
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$380.46 million
Price / Sales2.16
Cash Flow$1.51 per share
Price / Cash11.03
Book Value$5.58 per share
Price / Book2.98
Return on EquityN/A
Return on AssetsN/A
Consort Medical (OTCMKTS:CSRMY) Frequently Asked Questions
What is Consort Medical's stock symbol?
Consort Medical trades on the OTCMKTS under the ticker symbol "CSRMY."
How often does Consort Medical pay dividends? What is the dividend yield for Consort Medical?
Consort Medical announced a None dividend on Wednesday, December 13th. Shareholders of record on Friday, January 19th will be given a dividend of $0.087 per share on Monday, February 26th. The ex-dividend date is Thursday, January 18th. View Consort Medical's Dividend History.
Who are some of Consort Medical's key competitors?
Some companies that are related to Consort Medical include Intercept Pharmaceuticals (ICPT), Enanta Pharmaceuticals (ENTA), Atara Biotherapeutics (ATRA), ImmunoGen (IMGN), Innoviva (INVA), Radius Health (RDUS), Madrigal Pharmaceuticals (MDGL), Repligen (RGEN), Endo International (ENDP), Impax Laboratories (IPXL), Iovance Biotherapeutics (IOVA), Xencor (XNCR), Zogenix (ZGNX), Momenta Pharmaceuticals (MNTA), Theravance Biopharma (TBPH), Heron Therapeutics (HRTX), Mallinckrodt (MNK) and Prothena (PRTA).
Who are Consort Medical's key executives?
Consort Medical's management team includes the folowing people:
- Jonathan M. Glenn, Chief Executive, Executive Director (Age 47)
- Paul Hayes, Chief Financial Officer, Executive Director (Age 50)
- John W. Ilett, Group General Counsel, Company Secretary
- Keyvan Djamarani, Managing Director, Bespak
- Ian Muir, Managing Director, Aesica
- Peter J. Fellner, Non-Executive Independent Chairman of the Board (Age 74)
- Steve Crummett, Non-Executive Director
- Maria Charlotta Ginman-Jones, Non-Executive Director
- Andrew Joseph Hosty, Non-Executive Director (Age 51)
- Ian J. Nicholson, Non-Executive Director (Age 54)
Has Consort Medical been receiving favorable news coverage?
Media stories about CSRMY stock have trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Consort Medical earned a coverage optimism score of 0.19 on Accern's scale. They also assigned headlines about the company an impact score of 46.91 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Consort Medical?
Shares of CSRMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Consort Medical's stock price today?
One share of CSRMY stock can currently be purchased for approximately $16.65.
How big of a company is Consort Medical?
Consort Medical has a market capitalization of $818.60 million and generates $380.46 million in revenue each year.
MarketBeat Community Rating for Consort Medical (CSRMY)MarketBeat's community ratings are surveys of what our community members think about Consort Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consort Medical (OTCMKTS:CSRMY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Consort Medical (OTCMKTS:CSRMY)
No earnings announcements for this company have been tracked by MarketBeat.com
Consort Medical (OTCMKTS:CSRMY) Earnings Estimates
Current Year EPS Consensus Estimate: $0.86 EPS
Next Year EPS Consensus Estimate: $0.99 EPS
Consort Medical (OTCMKTS:CSRMY) Dividend Information
|Most Recent Dividend:||2/26/2018|
|Payout Ratio:||27.91% (Based on This Year's Estimates)|
24.24% (Based on Next Year's Estimates)
Consort Medical (OTCMKTS:CSRMY) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Consort Medical (OTCMKTS CSRMY)
No insider trades for this company have been tracked by MarketBeat.com
Consort Medical (OTCMKTS CSRMY) News Headlines
Consort Medical (OTCMKTS:CSRMY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Consort Medical (OTCMKTS CSRMY) Stock Chart for Monday, March, 19, 2018